Search - tctmd.com

Displaying 81 - 100 of 104

Sort: Relevancy | Date

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Shelley Wood

November 05, 2018

News Daily News

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

Caitlin E. Cox

July 30, 2018

News Features

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Caitlin E. Cox

May 02, 2018

News Daily News

Impella Use in Acute MI and Cardiogenic Shock: Clues From US Registry Data

Caitlin E. Cox

April 12, 2018

News Daily News

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

Todd Neale

October 02, 2017

News Industry News

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

May 05, 2017

News Conference News ACC 2017

Prioritizing Impella Support May Boost Cardiogenic Shock Survival, Pilot Study Suggests

Todd Neale

March 22, 2017

News Conference News TCT 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Todd Neale

October 29, 2016

News Industry News

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

September 27, 2016

News Daily News

FDA Approves Impella Left-Ventricular Heart Pumps for Cardiogenic Shock

Michael O'Riordan

April 08, 2016

News Daily News

登记图表显示出在 PCI 期间使用机械循环支持的趋势

L.A. McKeown

September 14, 2015

News Daily News

Un Registro Traza las Tendencias en materia de Soporte Circulatorio Mecánico durante la realización de PCI

L.A. McKeown

September 14, 2015

News Daily News

Registry Charts Trends in Mechanical Circulatory Support During PCI

L.A. McKeown

September 14, 2015

News Industry News

Thoratec trial pits HeartMate PHP against Abiomed’s Impella

September 04, 2015

News Daily News

现实中 LVAD 在被认为无法行 PCI 的危重患者中的使用颇具结局前景

L.A. McKeown

August 24, 2015

News Daily News

Real-World LVAD Use Promising in Patients Otherwise Considered Too Sick for PCI

L.A. McKeown

August 24, 2015

News Daily News

El Uso de DAVI en el Mundo Real es Prometedor en Pacientes Considerados, de Otra Forma, Demasiados Enfermos para ser Sometidos a una PCI

L.A. McKeown

August 24, 2015

News Industry News

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

August 18, 2015

News Daily News

Transradial Access Feasible, Beneficial in Cardiogenic Shock Patients

Jason Kahn

April 10, 2014

News Conference News Advances in Hemodynamic Support 2014

Advances in Hemodynamics: Meeting Encourages Conversation About Best Practices

Yael L. Maxwell

March 03, 2014

Advertisement

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

Impella Use in Acute MI and Cardiogenic Shock: Clues From US Registry Data

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

Prioritizing Impella Support May Boost Cardiogenic Shock Survival, Pilot Study Suggests

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare

FDA Approves Impella Left-Ventricular Heart Pumps for Cardiogenic Shock

登记图表显示出在 PCI 期间使用机械循环支持的趋势

Un Registro Traza las Tendencias en materia de Soporte Circulatorio Mecánico durante la realización de PCI

Registry Charts Trends in Mechanical Circulatory Support During PCI

Thoratec trial pits HeartMate PHP against Abiomed’s Impella

现实中 LVAD 在被认为无法行 PCI 的危重患者中的使用颇具结局前景

Real-World LVAD Use Promising in Patients Otherwise Considered Too Sick for PCI

El Uso de DAVI en el Mundo Real es Prometedor en Pacientes Considerados, de Otra Forma, Demasiados Enfermos para ser Sometidos a una PCI

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

Transradial Access Feasible, Beneficial in Cardiogenic Shock Patients

Advances in Hemodynamics: Meeting Encourages Conversation About Best Practices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content